Chapter 21 Pancreatic Network Control of Glucagon Secretion and Counterregulation

Methods in Enzymology

Volumn 467, Issue C, 2009, Pages 547-581

  Farhy, Leon S ^a   McCall, Anthony L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; PEPTIDE DERIVATIVE; STREPTOZOCIN; GLUCOSE; INSULIN;

CELL STIMULATION; COMPUTER MODEL; DIABETES MELLITUS; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN DEFICIENCY; INSULIN RELEASE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NONHUMAN; PANCREAS PERFUSION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SIMULATION; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BLOOD; EXPERIMENTAL DIABETES MELLITUS; FEEDBACK SYSTEM; METABOLISM; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REPRODUCIBILITY; SECRETION; SIGNAL TRANSDUCTION; SOMATOSTATIN CELL; THEORETICAL MODEL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEEDBACK, PHYSIOLOGICAL; GLUCAGON; GLUCAGON-SECRETING CELLS; GLUCOSE; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; RATS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SOMATOSTATIN-SECRETING CELLS;

EID: 71549167312     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)67021-X     Document Type: Review

References (114)

1. Ashcroft F.M., Proks P., Smith P.A., Ammala C., Bokvist K., and Rorsman P. Stimulus-secretion coupling in pancreatic beta cells. J. Cell. Biochem. 55 Suppl (1994) 54-65
2. Banarer S., McGregor V.P., and Cryer P.E. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 51 4 (2002) 958-965
3. Bell G.I., Pilkis S.J., Weber I.T., and Polonsky K.S. Glucokinase mutations, insulin secretion, and diabetes mellitus. Annu. Rev. Physiol. 58 (1996) 171-186
4. Bergman R.N., Ider Y.Z., Boeden C.R., and Cobelli C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236 (1979) E667-E677
5. Bergman R.N., Prager R., Volund A., and Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79 (1987) 790-800
6. Bertrand G., Gross R., Puech R., Loubatieres-Mariani M.M., and Bockaert J. Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas. Br. J. Pharmacol. 106 2 (1992) 354-359
7. Bolli G.B., and Fanelli C.G. Physiology of glucose counterregulation to hypoglycemia. Endocrinol. Metab. Clin. North Am. 28 (1999) 467-493
8. Breda E., Cavaghan M.K., Toffolo G., Polonsky K.S., and Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50 1 (2001) 150-158
9. Brelje T.C., Scharp D.W., and Sorenson R.L. Three-dimensional imaging of intact isolated islets of Langerhans with confocal microscopy. Diabetes 38 6 (1989) 808-814
10. Brunicardi F.C., Kleinman R., Moldovan S., Nguyen T.H., Watt P.C., Walsh J., and Gingerich R. Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated per fused human pancreas. Pancreas 23 3 (2001) 302-308
11. Brunicardi F.C., Atiya A., Moldovan S., Lee T.C., Fagan S.P., Kleinman R.M., Adrian T.E., Coy D.H., Walsh J.H., and Fisher W.E. Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas. Pancreas 27 4 (2003) e84-e89
12. Cabrera O., Jacques-Silva M.C., Speier S., Yang S.N., Köhler M., Fachado A., Vieira E., Zierath J.R., Kibbey R., Berman D.M., Kenyon N.S., Ricordi C., et al. Glutamate is a positive autocrine signal for glucagon release. Cell Metab. 7 6 (2008) 545-554
13. Cejvan K., Coy D.H., and Efendic S. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 52 5 (2003) 1176-1181
14. Cobelli C., Pacini G., Toffolo G., and Sacca L. Estimation of insulin sensitivity and glucose clearance from minimal model: New insights from labeled IVGTT. Am. J. Physiol. 250 (1986) E591-E598
15. Cobelli C., Brier D.M., and Ferrannini E. Modeling glucose metabolism in man: Theory and practice. Horm. Metab. Res. Suppl. 24 (1990) 1-10
16. Cryer P.E. Hypoglycemia is the limiting factor in the management of diabetes. Diabetes Metab. Res. Rev. 15 1 (1999) 42-46
17. Cryer P.E. Hypoglycemia the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45 7 (2002) 937-948
18. Cryer P.E., and Gerich J.E. Relevance of glucose counterregulatory systems to patients with diabetes: Critical roles of glucagon and epinephrine. Diabetes Care 6 1 (1983) 95-99
19. Cryer P.E., Davis S.N., and Shamoon H. Hypoglycemia in diabetes. Diabetes Care 26 (2003) 1902-1912
20. Diem P., Redmon J.B., Abid M., Moran A., Sutherland D.E., Halter J.B., and Robertson R.P. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J. Clin. Invest. 86 6 (1990) 2008-2013
21. Dumonteil E., Magnan C., Ritz-Laser B., Ktorza A., Meda P., and Philippe J. Glucose regulates proinsulin and prosomatostatin but not proglucagon messenger ribonucleic acid levels in rat pancreatic islets. Endocrinology 141 1 (2000) 174-180
22. Dunne M.J., Harding E.A., Jaggar J.H., and Squires P.E. Ion channels and the molecular control of insulin secretion. Biochem. Soc. Trans. 22 1 (1994) 6-12
23. Efendic S., Nylen A., Roovete A., and Uvnas-Wallenstein K. Effects of glucose and arginine on the release of immunoreactive somatostatin from the isolated perfused rat pancreas. FEBS Lett. 92 1 (1978) 33-35
24. Epstein S., Berelowitz M., and Bell N.H. Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man. J. Clin. Endocrinol. Metab. 51 (1980) 1227-1231
25. Farhy L.S. Modeling of oscillations in endocrine networks with feedback. Methods Enzymol. 384 (2004) 54-81
26. Farhy L.S., and McCall A.L. System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency. J. Diabetes Sci. Technol. 3 1 (2009) 21-33
27. Farhy L.S., and Veldhuis J.D. Joint pituitary-hypothalamic and intrahypothalamic autofeedback construct of pulsatile growth hormone secretion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 5 (2003) R1240-R1249
28. Farhy L.S., and Veldhuis J.D. Putative GH pulse renewal: Periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 6 (2004) R1030-R1042
29. Farhy L.S., and Veldhuis J.D. Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005) R1649-R1663
30. Farhy L.S., Straume M., Johnson M.L., Kovatchev B., and Veldhuis J.D. A construct of interactive feedback control of the GH axis in the male. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 1 (2001) R38-R51
31. Farhy L.S., Straume M., Johnson M.L., Kovatchev B., and Veldhuis J.D. Unequal autonegative feedback by GH models the sexual dimorphism in GH secretory dynamics. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 3 (2002) R753-R764
32. Farhy L.S., Bowers C.Y., and Veldhuis J.D. Model-projected mechanistic bases for sex differences in growth-hormone (GH) regulation in the human. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) R1577-R1593
33. Farhy L.S., Du Z., Zeng Q., Veldhuis P.P., Johnson M.L., Brayman K.L., and McCall A.L. Amplification of pulsatile glucagon secretion by switch-off of α-cell suppressing signals in streptozotocin treated rats. Am. J. Physiol. Endocrinol. Metab. 295 (2009) E575-E585
34. Fujitani S., Ikenoue T., Akiyoshi M., Maki T., and Yada T. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas. Metab. Clin. Exp. 45 2 (1996) 184-189
35. Fukuda M., Tanaka A., Tahara Y., Ikegami H., Yamamoto Y., Kumahara Y., and Shima K. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes 37 1 (1988) 81-88
36. Gedulin B.R., Rink T.J., and Young A.A. Dose-response for glucagonostatic effect of amylin in rats. Metabolism 46 (1997) 67-70
37. Genter P., Berman N., Jacob M., and Ipp E. Counterregulatory hormones oscillate during steady-state hypoglycemia. Am. J. Physiol. 275 5 (1998) E821-E829
38. Gerich J.E. Lilly lecture: Glucose counterregulation and its impact on diabetes mellitus. Diabetes 37 12 (1988) 1608-1617
39. Gerich J.E., Langlois M., Noacco C., Karam J.H., and Forsham P.H. Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect. Science 182 108 (1973) 171-173
40. Gopel S.O., Kanno T., Barg S., and Rorsman P. Patch-clamp characterisation of somatostatin-secreting-cells in intact mouse pancreatic islets. J. Physiol. 528 3 (2000) 497-507
41. + channels. J. Physiol. 528 (2000) 509-520
42. Grapengiesser E., Salehi A., Quader S.S., and Hellman B. Glucose induces glucagon release pulses antisynchronous with insulin and sensitive to purinoceptors inhibition. Endocrinology 147 (2006) 3472-3477
43. Grimmichova R., Vrbikova J., Matucha P., Vondra K., Veldhuis P., and Johnson M. Fasting insulin pulsatile secretion in lean women with polycystic ovary syndrome. Physiol. Res. 57 (2008) 1-8
44. Gromada J., Franklin I., and Wollheim C.B. α-Cells of the endocrine pancreas: 35 Years of research but the enigma remains. Endocr. Rev. 28 1 (2007) 84-116
45. Guyton J.R., Foster R.O., Soeldner J.S., Tan M.H., Kahn C.B., Koncz L., and Gleason R.E. A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release. Diabetes 27 (1978) 1027-1042
46. Havel P.J., and Ahren B. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 46 (1997) 801-807
47. Havel P.J., and Taborsky Jr. G.J. The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocr. Rev. 10 3 (1989) 332-350
48. Heimberg H., De Vos A., Pipeleers D., Thorens B., and Schuit F. Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization. J. Biol. Chem. 270 15 (1995) 8971-8975
49. Heimberg H., De Vos A., Moens K., Quartier E., Bouwens L., Pipeleers D., Van Schaftingen E., Madsen O., and Schuit F. The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells. Proc. Natl. Aca. Sci. USA 93 14 (1996) 7036-7041
50. Heise T., Heinemann T., Heller S., Weyer C., Wang Y., Strobel S., Kolterman O., and Maggs D. Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects. Metabolism 53 9 (2004) 1227-1232
51. Hermansen K., Christensen S.E., and Orskov H. Characterization of somatostatin release from the pancreas: The role of potassium. Scand. J. Clin. Lab. Invest. 39 8 (1979) 717-722
52. Hilsted J., Frandsen H., Holst J.J., Christensen N.J., and Nielsen S.L. Plasma glucagon and glucose recovery after hypoglycemia: The effect of total autonomic blockade. Acta Endocrinol. 125 5 (1991) 466-469
53. Hirsch B.R., and Shamoon H. Defective epinephrine and growth hormone responses in type I diabetes are stimulus specific. Diabetes 36 1 (1987) 20-26
54. Hoffman R.P., Arslanian S., Drash A.L., and Becker D.J. Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM. J. Pediatr. Endocrinol. 7 3 (1994) 235-244
55. Hope K.M., Tran P.O., Zhou H., Oseid E., Leroy E., and Robertson R.P. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: The "switch-off" hypothesis. Diabetes 53 6 (2004) 1488-1495
56. Huypens P., Ling Z., Pipeleers D., and Schuit F. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 43 8 (2000) 1012-1019
57. Inagaki N., Kuromi H., Gonoi T., Okamoto Y., Ishida H., Seino Y., Kaneko T., Iwanaga T., and Seino S. Expression and role of ionotropic glutamate receptors in pancreatic islet cells. FASEB J. 9 8 (1995) 686-691
58. Insel P.A., Liljenquist J.E., Tobin J.D., Sherwin R.S., Watkins P., Andres R., and Berman M. Insulin control of glucose metabolism in man. A new kinetic analysis. J. Clin. Invest. 55 (1975) 1057-1066
59. Ishihara H., Maechler P., Gjinovci A., Herrera P.L., and Wollheim C.B. Islet β-cell secretion determines glucagon release from neighboring α-cells. Nat. Cell Biol. 5 (2003) 330-335
60. Ito K., Maruyama H., Hirose H., Kido K., Koyama K., Kataoka K., and Saruta T. Exogenous insulin dose-dependently suppresses glucopenia-induced glucagon secretion from perfused rat pancreas. Metab. Clin. Exp. 44 3 (1995) 358-362
61. Jaspan J.B., Lever E., Polonsky K.S., and Van Cauter E. In vivo pulsatility of pancreatic islet peptides. Am. J. Physiol. 251 2 Pt 1 (1986) E215-E226
62. Kawai K., and Unger R.H. Inhibition of glucagon secretion by exogenous glucagon in the isolated, perfused dog pancreas. Diabetes 31 6 (1982) 512-515
63. Kawamori D., Kurpad A.J., Hu J., Liew C.W., Shih J.L., Ford E.L., Herrera P.L., Polonsky K.S., McGuinness O.P., and Kulkarni R.N. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 9 4 (2009) 350-361
64. Kieffer T.J., Heller R.S., Unson C.G., Weir G.C., and Habener J.F. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Endocrinology 137 11 (1996) 5119-5125
65. Klaff L.J., and Taborsky Jr. G.J. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia. Diabetes 36 5 (1987) 592-596
66. Kleinman R., Gingerich R., Wong H., Walsh J., Lloyd K., Ohning G., De Giorgio R., Sternini C., and Brunicardi F.C. Use of the Fab fragment for immunoneutralization of somatostatin in the isolated perfused human pancreas. Am. J. Surg. 167 1 (1994) 114-119
67. Kleinman R., Gingerich R., Ohning G., Wong H., Olthoff K., Walsh J., and Brunicardi F.C. The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas. Int. J. Pancreatol. 18 1 (1995) 51-57
68. Kovatchev B.P., Farhy L.S., Cox D.J., Straume M., Yankov V.I., Gonder-Frederick L.A., and Clarke W.L. Modeling insulin-glucose dynamics during insulin induced hypoglycemia. Evaluation of glucose counterregulation. J. Theor. Med. 1 (1999) 313-323
69. Kovatchev B.P., Straume M., Farhy L.S., and Cox D.J. Dynamic network model of glucose counterregulation in subjects with insulin-requiring diabetes. Methods Enzymol. 321 (2000) 396-410
70. Ludvigsen E., Olsson R., Stridsberg M., Janson E.T., and Sandler S. Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J. Histochem. Cytochem. 52 3 (2004) 391-400
71. Mari A. Assessment of insulin sensitivity with minimal model: Role of model assumptions. Am. J. Physiol. 272 (1997) E925-E934
72. Maruyama H., Hisatomi A., Orci L., Grodsky G.M., and Unger R.H. Insulin within islets is a physiologic glucagon release inhibitor. J. Clin. Invest. 74 6 (1984) 2296-2299
73. Matthews D.R., Hermansen K., Connolly A.A., Gray D., Schmitz O., Clark A., Orskov H., and Turner R.C. Greater in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and somatostatin secretory pulses. Endocrinology 120 6 (1987) 2272-2278
74. McCall A.L., Cox D.J., Crean J., Gloster M., and Kovatchev B.P. A novel analytical method for assessing glucose variability: Using CGMS in type 1 diabetes mellitus. Diabetes Technol. Ther. 8 6 (2006) 644-653
75. Meier J.J., Kjems L.L., Veldhuis J.D., Lefebvre P., and Butler P.C. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: Further evidence for the intraislet insulin hypothesis. Diabetes 55 4 (2006) 1051-1056
76. Pipeleers D.G., Schuit F.C., Van Schravendijk C.F., and Van de Winkel M. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117 3 (1985) 817-823
77. Pørksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia 45 1 (2002) 3-20
78. Portela-Gomes G.M., Stridsberg M., Grimelius L., Oberg K., and Janson E.T. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl. Immunohistochem. Mol. Morphol. 8 2 (2000) 126-132
79. Quon M.J., Cochran C., Taylor S.I., and Eastman R.C. Non-insulin mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes 43 (1994) 890-896
80. Ravier M.A., and Rutter G.A. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha cells. Diabetes 54 (2005) 1789-1797
81. Reaven G.M., Chen Y.D., Golay A., Swislocki A.L., and Jaspan J.B. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 64 1 (1987) 106-110
82. 2+-dependent action potentials. J. Gen. Physiol. 91 2 (1988) 223-242
83. Rorsman P., Berggren P.O., Bokvist K., Ericson H., Mohler H., Ostenson C.G., and Smith P.A. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 341 6239 (1989) 233-236
84. Salehi A., Quader S.S., Grapengiesser E., and Hellman B. Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon. Regul. Pept. 144 (2007) 43-49
85. Samols E., and Stagner J.I. Intra-islet regulation. Am. J. Med. 85 5A (1988) 31-35
86. Samols E., and Stagner J.I. Islet somatostatin-microvascular, paracrine, and pulsatile regulation. Metab. Clin. Exp. 39 9 Suppl 2 (1990) 55-60
87. Schuit F.C., Derde M.P., and Pipeleers D.G. Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 32 3 (1989) 207-212
88. Schuit F., De Vos A., Farfari S., Moens K., Pipeleers D., Brun T., and Prentki M. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J. Biol. Chem. 272 30 (1997) 18572-18579
89. Schuit F.C., Huypens P., Heimberg H., and Pipeleers D.G. Glucose sensing in pancreatic beta-cells: A model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 50 1 (2001) 1-11
90. Segel S.A., Paramore D.S., and Cryer P.E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51 3 (2002) 724-733
91. Silvestre R.A., Rodri{dotless}́guez-Gallardo J., Jodka C., Parkes D.G., Pittner R.A., Young A.A., and Marco J. Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E443-E449
92. Stagner J.I., Samols E., and Bonner-Weir S. Beta-alpha-delta pancreatic islet cellular perfusion in dogs. Diabetes 37 12 (1988) 1715-1721
93. Stagner J.I., Samols E., and Marks V. The anterograde and retrograde infusion of glucagon antibodies suggests that A cells are vascularly perfused before D cells within the rat islet. Diabetologia 32 3 (1989) 203-206
94. Steele R., Rostami H., and Altszuler N. A two-compartment calculator for the dog glucose pool in the nonsteady state. Fed. Proc. 33 (1974) 1869-1876
95. Strowski M.Z., Parmar R.M., Blake A.D., and Schaeffer J.M. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: An in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 141 1 (2000) 111-117
96. Sumida Y., Shima T., Shirayama K., Misaki M., and Miyaji K. Effects of hexoses and their derivatives on glucagon secretion from isolated perfused rat pancreas. Horm. Metab. Res. 26 5 (1994) 222-225
97. Taborsky Jr. G.J., Ahren B., and Havel P.J. Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 47 7 (1998) 995-1005
98. Tapia-Arancibia L., and Astier H. Glutamate stimulates somatostatin release from diencephalic neurons in primary culture. Endocrinology 123 (1988) 2360-2366
99. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358 (2008) 2545-2559
100. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
101. Tirone T.A., Norman M.A., Moldovan S., DeMayo F.J., Wang X.P., and Brunicardi F.C. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model. Pancreas 26 3 (2003) e67-e73
102. Toffolo G., De Grandi F., and Cobelli C. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 44 (1995) 845-854
103. Toffolo G., Breda E., Cavaghan M.K., Ehrmann D.A., Polonsky K.S., and Cobelli C. Quantitative indices of β-cell function during graded up&down glucose infusion from C-peptide minimal models. Am. J. Physiol. 280 (2001) 2-10
104. Uehara S., Muroyama A., Echigo N., Morimoto R., Otsuka M., Yatsushiro S., and Moriyama Y. Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans. Diabetes 53 4 (2004) 998-1006
105. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352 (1998) 837-853
106. Unger R.H. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28 (1985) 574-578
107. Utsumi M., Makimura H., Ishihara K., Morita S., and Baba S. Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion. Diabetologia 17 (1979) 319-323
108. Van Schravendijk C.F., Foriers A., Van den Brande J.L., and Pipeleers D.G. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121 5 (1987) 1784-1788
109. Wendt A., Birnir B., Buschard K., Gromada J., Salehi A., Sewing S., Rorsman P., and Braun M. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 53 4 (2004) 1038-1045
110. Xu E., Kumar M., Zhang Y., Ju W., Obata T., Zhang N., Liu S., Wendt A., Deng S., Ebina Y., Wheeler M.B., Braun M., et al. Intraislet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab. 3 (2006) 47-58
111. Yamasaki Y., Tiran J., and Albisser A.M. Modeling glucose disposal in diabetic dogs fed mixed meals. Am. J. Physiol. 246 (1984) E52-E61
112. Zhou H., Tran P.O., Yang S., Zhang T., LeRoy E., Oseid E., and Robertson R.P. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: The "switch-off" hypothesis. Diabetes 53 6 (2004) 1482-1487
113. Zhou H., Zhang T., Oseid E., Harmon J., Tonooka N., and Robertson R.P. Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats. Endocrinology 148 (2007) 2863-2869
114. Zhou H., Zhang T., Harmon J.S., Bryan J., and Robertson R.P. Zinc, not insulin, regulates the rat α-cell response to hypoglycemia in vivo. Diabetes 56 (2007) 1107-1112